Mumbai, India , is rapidly emerging as a vital hub for the manufacture of Lenacapavir Sodium API (CAS 2189684-53-3). Several organizations have established substantial manufacturing plants focusing on this critical antiviral compound. Identifying the definitive top manufacturers can be challengin